Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology
Autor: | Peter-Michael Rath, Methee Chayakulkeeree, Alessandro C. Pasqualotto, Christopher C. Kibbler, María José Buitrago, Thuy Le, Neil M Ampel, Flavio Queiroz-Telles, Ferry Hagen, Oliver A. Cornely, Paul E. Verweij, Ana Alastruey-Izquierdo, Ariya Chindamporn, Nelesh P. Govender, Carol A. Kauffman, Graeme Meintjes, Darius Armstrong-James, Chris Kenyon, Grégory Jouvion, Ilan S. Schwartz, Olusola Ayanlowo, Jean-Pierre Gangneux, John W Baddley, George Richard Thompson, Jasper Fuk-Woo Chan, David R. Andes, Tobias M. Hohl, Low Lee Lee, Andrej Spec, Cao Cun-wei, Robert Krause, Ebrahim Variava, Marisa H. Miceli, David C M Kong, Leili Chamani-Tabriz, Mohammad Taghi Hedayati, Bridget M. Barker, Nikolai Klimko, Leila Maria Lopes Bezerra |
---|---|
Přispěvatelé: | University of California [Davis] (UC Davis), University of California, Duke University [Durham], Chulalongkorn University [Bangkok], University of Michigan Medical School [Ann Arbor], University of Michigan [Ann Arbor], University of Michigan System-University of Michigan System, Instituto de Salud Carlos III [Madrid] (ISC), University of Arizona, University of Wisconsin-Madison, Imperial College London, University of Lagos, University of Maryland School of Medicine, University of Maryland System, The Pathogen and Microbiome Institute, Northern Arizona University [Flagstaff], State University of Rio de Janeiro, The University of Hong Kong (HKU), Mahidol University [Bangkok], University Hospital of Cologne [Cologne], Guangxi University [Nanning], Institut de recherche en santé, environnement et travail (Irset), Université d'Angers (UA)-Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), National Institute for Communicable Diseases [Johannesburg] (NICD), University of the Witwatersrand [Johannesburg] (WITS), University Medical Center [Utrecht], Mazandaran University of Medical Sciences, Memorial Sloan Kettering Cancer Center (MSKCC), Neuropathologie expérimentale / Experimental neuropathology, Institut Pasteur [Paris]-Université de Paris (UP), Maladies génétiques d'expression pédiatrique [CHU Trousseau], CHU Trousseau [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Institute of Tropical Medicine [Antwerp] (ITM), University College of London [London] (UCL), University of Ballarat [Australie] (FedUni), Institute of Biophysics [Graz], Medical University Graz, University of Cape Town, Ruhrlandklinik University Hospital, Washington University School of Medicine in St. Louis, Washington University in Saint Louis (WUSTL), Federal University of Technology - Paraná (UTFPR), Radboud University Medical Center [Nijmegen], University of Alberta, Federal University of Health Sciences of Porto Alegre = Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), University of California (UC), Université d'Angers (UA)-Université de Rennes (UR)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Institut Pasteur [Paris] (IP)-Université Paris Cité (UPCité), Maladies génétiques d'expression pédiatrique (U933), Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Trousseau [APHP] |
Rok vydání: | 2021 |
Předmět: |
medicine.medical_specialty
Consensus Endemic Diseases [SDV]Life Sciences [q-bio] International Cooperation Clinical Sciences Clinical Decision-Making Medizin MEDLINE lnfectious Diseases and Global Health Radboud Institute for Molecular Life Sciences [Radboudumc 4] Guidelines as Topic Global Health Microbiology Article Histoplasmosis Vaccine Related 03 medical and health sciences 0302 clinical medicine All institutes and research themes of the Radboud University Medical Center Risk Factors Biodefense Mycology Epidemiology medicine Animals Humans 030212 general & internal medicine Intensive care medicine 0303 health sciences Sporotrichosis 030306 microbiology Paracoccidioidomycosis business.industry Prevention Guideline medicine.disease 3. Good health Europe Emerging Infectious Diseases Good Health and Well Being Infectious Diseases Mycoses Medical Microbiology Public Health and Health Services Infection business Blastomycosis |
Zdroj: | Lancet Infectious Diseases, 21, 12, pp. E364-E374 Lancet Infect Dis Lancet Infectious Diseases, 21, E364-E374 The Lancet Infectious Diseases The Lancet Infectious Diseases, New York, NY : Elsevier Science ; The Lancet Pub. Group, 2001-, 2021, 21 (12), pp.e364-e374. ⟨10.1016/S1473-3099(21)00191-2⟩ The Lancet Infectious Diseases, 2021, 21 (12), pp.e364-e374. ⟨10.1016/S1473-3099(21)00191-2⟩ The Lancet. Infectious diseases, vol 21, iss 12 |
ISSN: | 1473-3099 1474-4457 |
DOI: | 10.1016/S1473-3099(21)00191-2⟩ |
Popis: | International audience; The global burden of the endemic mycoses (blastomycosis, coccidioidomycosis, emergomycosis, histoplasmosis, paracoccidioidomycosis, sporotrichosis, and talaromycosis) continues to rise yearly and these infectious diseases remain a leading cause of patient morbidity and mortality worldwide. Management of the associated pathogens requires a thorough understanding of the epidemiology, risk factors, diagnostic methods and performance characteristics in different patient populations, and treatment options unique to each infection. Guidance on the management of these infections has the potential to improve prognosis. The recommendations outlined in this Review are part of the "One World, One Guideline" initiative of the European Confederation of Medical Mycology. Experts from 23 countries contributed to the development of these guidelines. The aim of this Review is to provide an up-to-date consensus and practical guidance in clinical decision making, by engaging physicians and scientists involved in various aspects of clinical management. |
Databáze: | OpenAIRE |
Externí odkaz: |